Lesinurad per al tractament de la hiperuricèmia en pacients amb gota
Abstract
Gout is a chronic, disabling pathology caused by monosodium urate crystal diposit (UMS) and the resulting inflammation of the articular, periarticular and subcutaneous areas. Associated clinical manifestations are recurrent episodes of acute arthritis, chronic arthropaties, tofus (accumulation of UMS crystals) and nephropaties (nephrolithiasis for uric acid or chronic nephropathy).
Keywords
Uric acid; Lesinurad; AdultsBibliographic citation
Lesinurad per al tractament de la hiperuricèmia en pacients amb gota. Barcelona: Servei Català de la Salut; 2018.
Audience
Professionals
This item appears in following collections
The following license files are associated with this item:




